Nanomaterials in tumor immunotherapy: new strategies and challenges
X Zhu, S Li - Molecular Cancer, 2023 - Springer
Tumor immunotherapy exerts its anti-tumor effects by stimulating and enhancing immune
responses of the body. It has become another important modality of anti-tumor therapy with …
responses of the body. It has become another important modality of anti-tumor therapy with …
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
S Muhammad, T Fan, Y Hai, Y Gao, J He - Molecular Cancer, 2023 - Springer
Abstract Interleukin-2 (IL-2) and its receptor (IL-2R) are essential in orchestrating immune
responses. Their function and expression in the tumor microenvironment make them …
responses. Their function and expression in the tumor microenvironment make them …
Manganese-Enriched Zinc Peroxide Functional Nanoparticles for Potentiating Cancer Immunotherapy
M Zhou, S Liang, D Liu, K Ma, K Yun, J Yao, Y Peng… - Nano Letters, 2023 - ACS Publications
Immunotherapies have shown high clinical success, however, the therapeutical efficacy is
largely restrained by insufficient immune activation and an immunosuppressive …
largely restrained by insufficient immune activation and an immunosuppressive …
Titanium‐based nanoarchitectures for sonodynamic therapy‐involved multimodal treatments
Sonodynamic therapy (SDT) has considerably revolutionized the healthcare sector as a
viable noninvasive therapeutic procedure. It employs a combination of low‐intensity …
viable noninvasive therapeutic procedure. It employs a combination of low‐intensity …
Nanomaterials: breaking through the bottleneck of tumor immunotherapy
Y Kang, S Li - International Journal of Biological Macromolecules, 2023 - Elsevier
Immunotherapy exerts its excellent anti-tumor effects by stimulating and enhancing the
immune response of the body, and has become another important class of anti-tumor …
immune response of the body, and has become another important class of anti-tumor …
Artificial intelligence in cancer immunotherapy: applications in neoantigen recognition, antibody design and immunotherapy response prediction
Cancer immunotherapy is a method of controlling and eliminating tumors by reactivating the
body's cancer-immunity cycle and restoring its antitumor immune response. The increased …
body's cancer-immunity cycle and restoring its antitumor immune response. The increased …
mRNA delivery systems for cancer immunotherapy: lipid nanoparticles and beyond
ME Senti, LG Del Valle, RM Schiffelers - Advanced Drug Delivery Reviews, 2024 - Elsevier
Abstract mRNA-based vaccines are emerging as a promising alternative to standard cancer
treatments and the conventional vaccines. Moreover, the FDA-approval of three nucleic acid …
treatments and the conventional vaccines. Moreover, the FDA-approval of three nucleic acid …
Metal-Based Nanoparticles for Cancer Metalloimmunotherapy
IH Suliman, K Kim, W Chen, Y Kim, JH Moon, S Son… - Pharmaceutics, 2023 - mdpi.com
Although the promise of cancer immunotherapy has been partially fulfilled with the
unprecedented clinical success of several immunotherapeutic interventions, some issues …
unprecedented clinical success of several immunotherapeutic interventions, some issues …
Global serum profiling: an opportunity for earlier cancer detection
A Sala, JM Cameron, PM Brennan, EJ Crosbie… - Journal of Experimental …, 2023 - Springer
The advances in cancer research achieved in the last 50 years have been remarkable and
have provided a deeper knowledge of this disease in many of its conceptual and …
have provided a deeper knowledge of this disease in many of its conceptual and …
TRAIL-sensitizing effects of flavonoids in cancer
A Luiz-Ferreira, T Pacifico, ÁC Cruz, F Laudisi… - International Journal of …, 2023 - mdpi.com
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) represents a promising
anticancer agent, as it selectively induces apoptosis in transformed cells without altering the …
anticancer agent, as it selectively induces apoptosis in transformed cells without altering the …